Disease Progression in Women With X-linked Adrenoleukodystrophy

Who May Qualify: 1. Women aged 18 years old or older. 2. Diagnosis of X-linked ALD based on genetic testing, altered VLCFA levels, or family history. 3. Willing to undergo annual follow-up visits, including brain and spinal cord MRI scans. 4. Provision of written willing to sign a consent form. 5. Affiliation or beneficiary of a French social security system or of such a regime. Who Should NOT Join This Trial: 1. Any condition that in the opinion of the investigator are likely to adversely affect the study participation, interfere with study compliance, or confound the study results. 2. Under treatment or previous treatment with leriglitazone. 3. Pregnant or lactating women. 4. Subjects benefiting from laws aimed at protecting vulnerable adults: subjects being deprived of liberty by judicial or administrative decision, subjects under guardianship. 5. Participation in an interventional clinical trial. Always talk to your doctor about whether this trial is right for you.